Janssen reaches Akeega approval milestone
Treatment involves the treatment of adults with metastatic castration-resistant prostate cancer
Read More
Tag: akeega
Positive CHMP opinion for Janssen’s AKEEGA
If approved company’s prostate cancer therapy will be the first dual-action tablet available in EU
Read More
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
- Alzecure shares new preclinical data on NeuroRestore ACD856 at AD/PD conference
- Samsung Bioepis signs partnership with Sandoz for next‑generation biosimilars
- Atrogi begins dosing first subjects in human trial of ATR-258
- R1 Therapeutics launches with $77.5m to advance hyperphosphatemia treatment
